Drug LitigationHas the FDA Warned against the Use of Lexapro?

April 5, 2012

The Food and Drug Administration (FDA) has been clear that Lexapro (escitralopram) may present some very real risks to the children of women who take Lexapro and other antidepressants during pregnancy. According to research published in well-respected medical journals, prenatal exposure to Lexapro has been linked to persistent pulmonary hypertension (PPHN) and serious heart, brain, and abdominal birth defects.

 

Are you concerned that your child may have been injured as a result of your Lexapro prescription? Your questions are appropriate and they deserve clear answers. And if the answer is yes, then your family’s rights may have been violated. Find out about your options by contacting the attorneys and professionals at Nachawati Law Group today. With years of experience and dedicated expertise, we’re ready to help you. For a free consultation, call us at 1.866.545.8364 or email [email protected]

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy